S9-CMC1 TFA
S9-CMC1 TFA is a covalent peptide lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 value of 2.53 μM. S9-CMC1 TFA specifically recognizes Cys360 in the enzyme-active region. S9-CMC1 TFA inhibits LSD1 activity, increasing H3K4me1 and H3K4me2 levels, leading to G1 cell cycle arrest and apoptosis and inhibiting cell proliferation. S9-CMC1 TFA significantly inhibits tumor growth in A549 xenograft animal models.
For research use only. We do not sell to patients.
- Formula: C97H151F3N32O17S2
- Molecular Weight:2158.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Chemical Information
-
Molecular Weight 2158.57
-
Formula C97H151F3N32O17S2
-
Sequence
Ac-Pro-Arg-cyclo(Cys-Phe-Leu-Val-Met)-Lys-Pro-Arg-Arg-Arg-Arg-Trp-NH2 (Cyclization Bridge via Benzene-1,3-bismethylene: Cys3-Met7)
-
Sequence Shortening
Ac-PR-Cyclo(CFLVM)-KPRRRRW-NH2 (Cyclization Bridge via Benzene-1,3-bismethylene: Cys3-Met7)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz